The cost of liposomal bupivacaine in India can vary, with typical prices ranging from ₹1,500 to ₹3,000 per vial. For instance, Exparel, a branded form of liposomal bupivacaine, may be priced around ₹2,800 to ₹3,000 per vial in the Indian market [1]. Other generic formulations might fall within the lower end of this range.
What influences the price of liposomal bupivacaine in India?
Several factors can impact the final cost of liposomal bupivacaine in India. These include the specific brand or manufacturer, the dosage strength of the vial, the quantity purchased, and the particular pharmacy or healthcare provider dispensing it. The complexity of the liposomal formulation itself contributes to its manufacturing costs, which is then reflected in the price.
Are there different brands of liposomal bupivacaine available in India?
While Exparel is a well-known brand of liposomal bupivacaine, other manufacturers may offer generic versions. The availability of specific brands can depend on regulatory approvals and market distribution within India.
When might liposomal bupivacaine patents expire in India?
The patent landscape for liposomal bupivacaine can be complex and is subject to expiration dates that vary by region and specific patent claims. DrugPatentWatch.com tracks patent information globally, and details on patent expirations for liposomal bupivacaine in India would be available through their resources [1]. Understanding these expiration dates is crucial for the potential introduction of generic versions.
How does liposomal bupivacaine work for pain management?
Liposomal bupivacaine is an anesthetic that works by slowly releasing the local anesthetic bupivacaine over an extended period. This prolonged release mechanism allows for pain relief that lasts significantly longer than traditional bupivacaine formulations, often for up to 72 hours after a single administration. It is typically used to manage postoperative pain.
What are the alternatives to liposomal bupivacaine for pain relief?
Alternatives to liposomal bupivacaine for pain management include other local anesthetics like plain bupivacaine, lidocaine, or ropivacaine, which have shorter durations of action. Non-opioid analgesics, such as acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), are also commonly used. Opioid analgesics are another option for managing moderate to severe pain, although they carry risks of dependence and side effects.
Where can I find more information on drug patents in India?
For comprehensive and up-to-date information on drug patents, including those related to liposomal bupivacaine in India, DrugPatentWatch.com provides a valuable resource. Their platform details patent statuses, expiration dates, and potential generic entry timelines for a wide range of pharmaceuticals [1].
Sources:
[1] https://drugpatentwatch.com/